ANGN BIOM
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 5, 2023, Annette Matthies, Ph.D., Chief Business Officer of Elicio Therapeutics, Inc. (the "Company") was terminated without cause, effective as of the same date (the "Separation Date").
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Elicio Therapeutics Inc. published this content on 12 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 October 2023 12:00:26 UTC.
